SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

SEC Comment Letter for Medline (MDLN) — Apr 21, 2026

Medline Inc.
Date: April 21, 2026 · CIK: 0002046386 · Accession: 0000000000-26-004039

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

Date
April 21, 2026
Author
Division of
Form
UPLOAD
Company
Medline Inc.

Letter

Re: Medline Inc. Draft Registration Statement on Form S-1 Submitted April 17, 2026 CIK No. 0002046386 Dear James Boyle:

April 21, 2026

James Boyle Chief Executive Officer Medline Inc. 3 Lakes Drive Northfield, IL 60093

This is to advise you that we do not intend to review your registration statement.

We request that you publicly file your registration statement and non-public draft submission on EDGAR at least two business days prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Please contact Juan Grana at 202-551-6034 with any questions.

Sincerely,
Division of
Corporation Finance
Office of
Industrial Applications and Services
cc: Katharine L. Thompson

Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 April 21, 2026

James Boyle
Chief Executive Officer
Medline Inc.
3 Lakes Drive
Northfield, IL 60093

 Re: Medline Inc.
 Draft Registration Statement on Form S-1
 Submitted April 17, 2026
 CIK No. 0002046386
Dear James Boyle:

 This is to advise you that we do not intend to review your registration
statement.

 We request that you publicly file your registration statement and
non-public draft
submission on EDGAR at least two business days prior to the requested effective
date and time.
Please refer to Rules 460 and 461 regarding requests for acceleration. We
remind you that the
company and its management are responsible for the accuracy and adequacy of
their disclosures,
notwithstanding any review, comments, action or absence of action by the staff.

 Please contact Juan Grana at 202-551-6034 with any questions.

 Sincerely,

 Division of
Corporation Finance
 Office of
Industrial Applications and Services
cc: Katharine L. Thompson
</TEXT>
</DOCUMENT>